Benzinga | Aug 11, 2020 07:20AM EDT

Axovant Gene Therapies Q1 EPS $(0.20) Up From $(1.23) YoY

Axovant Gene Therapies (NASDAQ:AXGT) reported quarterly losses of $(0.20) per share. This is a 83.74 percent increase over losses of $(1.23) per share from the same period last year.